Cargando…

Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era

We aimed to investigate the prognostic value of radiation interruptions at different times on the overall survival (OS) and disease‐free survival (DFS) of patients with nasopharyngeal carcinoma receiving intensity‐modulated radiation therapy. Totally, 4510 patients were identified from a well‐establ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xing‐Li, Zhou, Guan‐Qun, Lin, Li, Zhang, Lu‐Lu, Chen, Fo‐Ping, Lv, Jia‐Wei, Kou, Jia, Wen, Dan‐Wan, Ma, Jun, Sun, Ying, Mao, Yan‐Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826475/
https://www.ncbi.nlm.nih.gov/pubmed/33107201
http://dx.doi.org/10.1002/cam4.3580
_version_ 1783640529093787648
author Yang, Xing‐Li
Zhou, Guan‐Qun
Lin, Li
Zhang, Lu‐Lu
Chen, Fo‐Ping
Lv, Jia‐Wei
Kou, Jia
Wen, Dan‐Wan
Ma, Jun
Sun, Ying
Mao, Yan‐Ping
author_facet Yang, Xing‐Li
Zhou, Guan‐Qun
Lin, Li
Zhang, Lu‐Lu
Chen, Fo‐Ping
Lv, Jia‐Wei
Kou, Jia
Wen, Dan‐Wan
Ma, Jun
Sun, Ying
Mao, Yan‐Ping
author_sort Yang, Xing‐Li
collection PubMed
description We aimed to investigate the prognostic value of radiation interruptions at different times on the overall survival (OS) and disease‐free survival (DFS) of patients with nasopharyngeal carcinoma receiving intensity‐modulated radiation therapy. Totally, 4510 patients were identified from a well‐established big‐data intelligence platform. Optimal interruption thresholds were identified using Recursive partitioning analyses. Actuarial rates were plotted using the Kaplan–Meier method and were compared using the log‐rank test. Patients with preceding interruptions ≥1 d (5‐year OS, 89.6% vs. 85.7%, p < 0.001; 5‐year DFS, 81.4% vs. 76.4%, p < 0.001), or latter interruptions ≥4 d (88.4% vs. 82.3%, p < 0.001; 79.2% vs. 75.1%, p = 0.006) showed significant detrimental effects on OS and DFS than patients without those interruptions. However, no significant lower survival was identified in latter interruptions ≥1 d (5‐year OS: 89.0% vs. 86.7%, p = 0.053; 5‐year DFS, 80.2% vs. 77.8%, p = 0.080). Latter interruptions ≥4 d was an independent unfavorable prognostic factor for OS (HR, 1.404; 95% CI, 1.143–1.723, p = 0.001) and DFS (HR, 1.351; 95% CI, 1.105–1.652, p = 0.003) in multivariate analysis. Radiation interruptions longer than 3 days that occurred in the latter period of treatment with IMRT were independent factors in poorer survival. Efforts are needed to minimize radiation interruptions and improve the timely provision of treatment.
format Online
Article
Text
id pubmed-7826475
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78264752021-02-01 Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era Yang, Xing‐Li Zhou, Guan‐Qun Lin, Li Zhang, Lu‐Lu Chen, Fo‐Ping Lv, Jia‐Wei Kou, Jia Wen, Dan‐Wan Ma, Jun Sun, Ying Mao, Yan‐Ping Cancer Med Clinical Cancer Research We aimed to investigate the prognostic value of radiation interruptions at different times on the overall survival (OS) and disease‐free survival (DFS) of patients with nasopharyngeal carcinoma receiving intensity‐modulated radiation therapy. Totally, 4510 patients were identified from a well‐established big‐data intelligence platform. Optimal interruption thresholds were identified using Recursive partitioning analyses. Actuarial rates were plotted using the Kaplan–Meier method and were compared using the log‐rank test. Patients with preceding interruptions ≥1 d (5‐year OS, 89.6% vs. 85.7%, p < 0.001; 5‐year DFS, 81.4% vs. 76.4%, p < 0.001), or latter interruptions ≥4 d (88.4% vs. 82.3%, p < 0.001; 79.2% vs. 75.1%, p = 0.006) showed significant detrimental effects on OS and DFS than patients without those interruptions. However, no significant lower survival was identified in latter interruptions ≥1 d (5‐year OS: 89.0% vs. 86.7%, p = 0.053; 5‐year DFS, 80.2% vs. 77.8%, p = 0.080). Latter interruptions ≥4 d was an independent unfavorable prognostic factor for OS (HR, 1.404; 95% CI, 1.143–1.723, p = 0.001) and DFS (HR, 1.351; 95% CI, 1.105–1.652, p = 0.003) in multivariate analysis. Radiation interruptions longer than 3 days that occurred in the latter period of treatment with IMRT were independent factors in poorer survival. Efforts are needed to minimize radiation interruptions and improve the timely provision of treatment. John Wiley and Sons Inc. 2020-10-27 /pmc/articles/PMC7826475/ /pubmed/33107201 http://dx.doi.org/10.1002/cam4.3580 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Yang, Xing‐Li
Zhou, Guan‐Qun
Lin, Li
Zhang, Lu‐Lu
Chen, Fo‐Ping
Lv, Jia‐Wei
Kou, Jia
Wen, Dan‐Wan
Ma, Jun
Sun, Ying
Mao, Yan‐Ping
Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
title Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
title_full Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
title_fullStr Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
title_full_unstemmed Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
title_short Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
title_sort prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826475/
https://www.ncbi.nlm.nih.gov/pubmed/33107201
http://dx.doi.org/10.1002/cam4.3580
work_keys_str_mv AT yangxingli prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera
AT zhouguanqun prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera
AT linli prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera
AT zhanglulu prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera
AT chenfoping prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera
AT lvjiawei prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera
AT koujia prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera
AT wendanwan prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera
AT majun prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera
AT sunying prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera
AT maoyanping prognosticvalueofradiationinterruptionindifferentperiodsfornasopharyngealcarcinomapatientsintheintensitymodulatedradiationtherapyera